• 1
    Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993; 119:312323.MEDLINE
  • 2
    Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and the related analogues. Proc Natl Acad Sci U S A 1991; 88:84958499.MEDLINE
  • 3
    Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:16571661.MEDLINE
  • 4
    Lai CL, Ching CK, Tung AKM, Li E, Young J, Hill A, Wong BCY, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatits B surface antigen carriers: a placebo-controlled trial. Hepatology 1997; 25:241244.MEDLINE
  • 5
    Larder BA, Kemp SD, Harrigan PR. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 1995; 269:696699.MEDLINE
  • 6
    Poch O, Sauvaget I, Delarue M, Tordo N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 1989; 12:38673874.
  • 7
    Back NKT, Nijhuis M, Keulen W, Boucher CAB, Oude Essink BB, van Kuilenburg ABP, van Gennip AH, et al. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J 1996; 15:40404049.MEDLINE
  • 8
    Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982; 29:403415.MEDLINE
  • 9
    Ling RD, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplanted recipients with lamivudine. Hepatology 1996; 24:711713.MEDLINE
  • 10
    Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in the HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714717.MEDLINE
  • 11
    Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:2022.MEDLINE
  • 12
    Fischer KP, Tyrrell DLJ. Generation of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(-)-beta-L-2′,3′-dideoxy-3′-thiacytidine) in vitro. Antimicrob Agents Chemother 1996; 40:19571960.MEDLINE
  • 13
    Aye TT, Bartholomeusz AJ, Shaw T, Bowden DS, Breschkin AM, McMillan JS, Angus P, et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997; 26:11481153.MEDLINE
  • 14
    Scaglioni PP, Melegari M, Wands JR. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol 1997; 71:345353.MEDLINE
  • 15
    Fallows DA, Goff SP. Mutations in the e sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J Virol 1995; 69:30673072.MEDLINE
  • 16
    Seeger C, Baldwin B, Tennant B. Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts. J Virol 1989; 63:68176825.
  • 17
    Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current protocols in molecular biology. New York: Wiley. 1989;.
  • 18
    Pugh JC, Yaginuma K, Koike K, Summers J. Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J Virol 1988; 62:35133516.MEDLINE
  • 19
    Scaglioni PP, Melegari M, Wands JR. Characterization of hepatitis B virus core mutants that inhibit viral replication. Virology 1994; 205:112120.MEDLINE
  • 20
    Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994; 199:292300.MEDLINE
  • 21
    Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, Gallo RC. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 1994; 266:801805.MEDLINE
  • 22
    Chang LJ, Ganem D, Varmus HE. Effects of insertional and point mutations on the functions of duck hepatitis B virus polymerase. J Virol 1990; 64:55535558.MEDLINE
  • 23
    Bartenschlager R, Junker-Niepmann M, Schaller H. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 1990; 64:53245332.MEDLINE
  • 24
    Richman DD. The implications of drug resistance for strategies of combination antiviral chemotherapy. Antiviral Res 1996; 29:3133.MEDLINE
  • 25
    Wands JR, Carpenter CCJ, Davis TT. Hepatitis B in an oncology unit. Morbid Mortal 1973; 22:294296.